- Report
- February 2024
- 468 Pages
Global
From €4661EUR$4,799USD£4,021GBP
- Report
- June 2023
- 600 Pages
Global
From €3497EUR$3,600USD£3,016GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Drug Pipelines
- April 2024
- 120 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- January 2024
- 150 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Drug Pipelines
- March 2024
- 180 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Report
- July 2023
- 290 Pages
Global
From €3497EUR$3,600USD£3,016GBP
- Report
- July 2020
- 416 Pages
Global
From €4720EUR$4,860USD£4,072GBP
- Report
- November 2022
- 154 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- October 2018
- 32 Pages
Global
From €9713EUR$10,000USD£8,379GBP
- Drug Pipelines
- December 2019
- 134 Pages
Global
From €3399EUR$3,500USD£2,933GBP
- Drug Pipelines
- December 2019
- 80 Pages
Global
From €3399EUR$3,500USD£2,933GBP
- Drug Pipelines
- May 2018
- 70 Pages
Global
From €3399EUR$3,500USD£2,933GBP
- Drug Pipelines
- February 2020
- 65 Pages
Global
From €3399EUR$3,500USD£2,933GBP
- Drug Pipelines
- December 2019
- 63 Pages
Global
From €3399EUR$3,500USD£2,933GBP
Tumor suppressor drugs are a type of oncology drug used to treat cancer. They work by inhibiting the growth of cancer cells, either by blocking the growth of new cells or by killing existing cells. Tumor suppressors are typically used in combination with other treatments, such as chemotherapy or radiation therapy, to maximize the effectiveness of the treatment. They are also used to reduce the risk of recurrence of cancer after treatment.
Tumor suppressors are typically administered orally or intravenously, depending on the type of cancer being treated. Common side effects of tumor suppressors include nausea, vomiting, fatigue, and hair loss.
The tumor suppressor market is a rapidly growing segment of the oncology drug market. As the number of cancer cases continues to rise, the demand for effective treatments is increasing. This has led to an increase in research and development of new tumor suppressor drugs, as well as the development of new delivery methods.
Some companies in the tumor suppressor market include Novartis, Merck, Pfizer, and AstraZeneca. Show Less Read more